S100B released from melanoma cells is a damage-associated molecular pattern protein that may contribute to tumour-associated inflammation and activate signalling pathways in tumour cells via receptors for advanced glycation end products, thereby promoting melanoma progression (26, 33, 34). The gene discussed is S100B; the disease is neoplasm.